AFWM
RXRX icon

Abich Financial Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Abich Financial Wealth Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7K Buy
1,063
+771
+264% +$5.53K 0.02% 228
2024
Q2 		$2.19K Buy
292
+271
+1,290% +$2.36K ﹤0.01% 476
2024
Q1 		$209 Buy
+21
New +$234 ﹤0.01% 481

Other funds holding RXRX

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Abich Financial Wealth Management's RXRX Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Recursion Pharmaceuticals (RXRX) stake by 264% in Q3 2024, buying an estimated $5.53K and bringing the position to 1,063 shares worth $7K. The position accounts for 0.02% of the portfolio, ranked #228.

Abich Financial Wealth Management first reported a position in RXRX in Q1 2024 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold RXRX as of Q3 2024.

  • Abich Financial Wealth Management held 1,063 shares of Recursion Pharmaceuticals worth $7K as of Q3 2024.
  • Abich Financial Wealth Management bought 771 Recursion Pharmaceuticals shares in Q3 2024, an estimated $5.53K.
  • Recursion Pharmaceuticals made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2024, its #228 holding.
  • Abich Financial Wealth Management first reported a position in Recursion Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.